News
A new high-sensitive wide-range CRP test available by Wako Chemicals GmbH
Since mid 2011 a new CRP test with the designation CRP-HS II LT is available for the quantitative determination in serum and plasma. The price will be nearly the same as the current Wako product.
µTASWakoTM i30 – Market launch: CE-marking and U.S. FDA clearance completed
Wako Chemicals GmbH now offers the biomarker tests AFP-L3% and DCP for Hepatocellular Carcinoma (HCC) using the new µTASWakoTM i30 instrument as CE-marked in vitro diagnostic products.
Wako Chemicals GmbH launches a new high-sensitive wide-range CRP test
In spring 2011 a new CRP test with the designation CRP-HS II LT is available for the quantitative determination in serum and plasma. The price will be nearly the same as the current Wako product.
µTASWakoTM i30 – new generation of clinical analyzers
Wako Chemical GmbH proudly presents at the Medica 2010 exhibition (Nov 17th to 20th, Dusseldorf, Germany) a milestone in laboratory medicine, the clinical analyzer µTASWakoTM i30, on display at its booth B38 in hall 2.
Importance of hyaluronic acid determination in patients with thalassemia demonstrated for the first time
Clinicians of the “Aghia Sophia” Children’s Hospital in Athens, Greece, published for the first time results of hyaluronic acid determinations (Wako’s HA LT test) using a Siemens ADVIA® 1800 Clinical Chemistry Analyzer and the Hepascore algorithm in 201 patients with thalassemia major.
Hyaluronic Acid LT enables automation of Hepascore
Dr. J. Guéchot from the hospital St. Antoine in Paris and the French Fibrostar study group published for the first time results of the fully automated Hepascore using HA LT, α2-macroglobulin, GGT and total Bilirubin on an Olympus AU640 analyser.
Automated Hyaluronic Acid LT test in new packaging size
From September 2009 Wako offers the HA LT test kit in a smaller packaging size. Thus HA LT is also appropriate for laboratories with a lower test throughput.
First Evaluation of HCC biomarkers AFP-L3% and DCP in Turkey
At the 5th APASL Single Topic Conference in May 2009 in Istanbul, preliminary results of a study about the HCC biomarkers AFP-L3% and DCP conducted by Prof. Dr. A.K. Doekmeci and colleagues from the Department of Gastroenterology of the Ankara University School of Medicine were presented.
First Evaluation of HCC biomarkers AFP-L3% and DCP in Egypt
During a seminar at May 14th 2009 in Cairo, Prof. Dr. Imam Waked from the National Liver Institute in Menoufiya presented first study results about the HCC biomarkers AFP-L3% und DCP.
More...
HCC biomarkers AFP-L3% and DCP by Wako evaluated for the first time in Germany
At the annual congress of the German Association for the Study of the Liver (GASL) in January 2009 in Heidelberg, researchers from the University Hospitals Essen and Mainz presented first study results about the HCC biomarkers AFP-L3% und DCP.